NEW YORK – SpeeDx announced today it has raised a total of $15 million from a US investment group. The Sydney, Australia-based molecular diagnostics developer said it had raised up to $10 million in additional equity investment from US-based Northpond Ventures, following an original investment of $5 million in April 2019.
The funds will help expedite the firm's international expansion and leverage strategic relationships with global partners, CEO Colin Denver said in a statement.